Genus Completes Private Placement
07 Novembro 2003 - 9:10PM
PR Newswire (US)
Genus Completes Private Placement SUNNYVALE, Calif., Nov. 7
/PRNewswire-FirstCall/ -- Genus, Inc. today announced that it has
completed a private placement of approximately 6.4 million shares
of its common stock at a per share price of $5.25. The offering
resulted in gross proceeds to the company of approximately $33.0
million. The purchase price of the shares represents approximately
a 5 percent discount on the average closing price for 10 days prior
to the close on November 7, 2003. No warrants were issued in this
transaction. The company stated that it expects to use the net
proceeds of the offering for working capital and general corporate
purposes. Halpern Capital, Inc. acted as the lead placement agent
to Genus for this private placement. This press release does not
constitute an offer to sell or the solicitation of an offer to buy
any security. The shares have not been registered under the
Securities Act of 1933 or applicable state securities laws and may
not be offered or sold in the United States absent registration
under the Securities Act and applicable state securities laws or an
applicable exemption from registration requirements. Genus has
agreed to file a registration statement covering the resale of the
shares. Except for the historical information contained herein, the
matters set forth in this press release, including the expected use
of proceeds of the offering, are forward-looking statements within
the meaning of the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements are subject to risks and uncertainties that may cause
actual results to differ materially, including the effect of the
offering on Genus' share price, changing customer requirements, and
the effects of technological advances and competition. For a
discussion of additional factors that may cause results to differ,
see Genus' SEC reports, including its Quarterly Report on Form 10-Q
for the quarter ended June 30, 2003 and Form 10-K for the year
ended December 31, 2002. These forward-looking statements speak
only as of the date hereof. Genus disclaims any intent or
obligation to update these forward-looking statements. About
Halpern Capital: Halpern Capital, Inc. is an "idea driven"
sell-side equity research and investment-banking boutique involved
in facilitating management restructurings, private placements and
leveraged buyouts. Halpern Capital founded by Baruch Halpern, has
its offices in Florida and associates in New York, California and
Texas. The firm brings a flexible and focused approach to the
private placement in public entity (PIPE) market, offering a wide
range of banking services on a selective basis. Halpern Capital
completed over $300 million in financings over the last few years.
Halpern Capital, Inc. is a NASD registered broker dealer.
Additional information can be found at
http://www.halperncapital.com/. About Genus: Genus, Inc.
manufactures critical deposition processing products for the global
semiconductor industry and the data storage industry. To enable the
production of intricate micro computer chips and electronic storage
devices, Genus offers its STRATAGEM and LYNX series
production-proven equipment for 200mm and 300mm semiconductor
production, and offers thin film deposition products for chemical
vapor deposition (CVD), atomic layer deposition (ALD), and
pre-clean capabilities. Genus is at the forefront of market and
technology developments in the ALD marketplace, which is gaining
acceptance worldwide as a critical technology for sub 0.13-micron
production of computer chips and electronic storage devices. Genus'
customers include semiconductor and data storage manufacturers
located throughout the United States, Europe and the Pacific Rim
including Korea, Japan and Taiwan. Founded in 1981, the company is
headquartered in Sunnyvale, California. For additional information
visit Genus' web site at http://www.genus.com/. STRATAGEM, LYNX2(R)
and LYNX3(tm) are trademarks of Genus, Inc. DATASOURCE: Genus, Inc.
CONTACT: Trine Pierik of Positio Public Relations, Inc.,
+1-650-815-1006, or , or Irene Dunlop of Genus, Inc, +1-408-747
7140, ext. 1140 Web site: http://www.halperncapital.com/ Web site:
http://www.genus.com/
Copyright
Genus (NASDAQ:GGNS)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Genus (NASDAQ:GGNS)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre Genus (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Genus (MM)